Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Aus. Peptide Conferenc...Aus. Peptide Conference
Not Confirmed
Not Confirmed
12-17 October, 2025
BioPlus Interphex Kore...BioPlus Interphex Korea
Not Confirmed
Not Confirmed
15-17 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Aus. Peptide Conferenc...Aus. Peptide Conference
Industry Trade Show
Not Confirmed
12-17 October, 2025
BioPlus Interphex Kore...BioPlus Interphex Korea
Industry Trade Show
Not Confirmed
15-17 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-are-building-capabilities-to-stay-ahead-of-the-curve-and-align-with-future-needs-of-global-healthcare
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
15 Oct 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/novo-nordisk-pens-21b-deal-omeros-stalled-pnh-drug
18 Aug 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/fda-delays-omeros-2nd-attempt-transplant-drugs-approval-3-months
14 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250814171073/en/Omeros-Corporation-Reports-Second-Quarter-2025-Financial-Results
11 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250811960801/en/Omeros-Corporation-to-Announce-Second-Quarter-Financial-Results-on-August-14-2025
25 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250725705443/en/Omeros-Corporation-Announces-Pricing-of-%2422-Million-Registered-Direct-Offering
27 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250627829521/en/Omeros-Submits-Narsoplimab-Marketing-Authorization-Application-to-the-European-Medicines-Agency-for-the-Treatment-of-TA-TMA
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE